본문 바로가기
KERD
논문KCI 등재

Functional characterization of naturally-occurring constitutively activating/inactivating mutations in equine follicle-stimulating hormone receptor

2

조회

0

다운로드

5

인용

0

참고문헌

키워드

초록

Objective: Follicle-stimulating hormone (FSH) is the central hormone involved in mammalian reproduction, maturation at puberty, and gamete production that mediates its function by control of follicle growth and function. The present study investigated the mutations involved in the regulation of FSH receptor (FSHR) activation. Methods: We analyzed seven naturally-occurring mutations that were previously reported in human FSHR (hFSHR), in the context of equine FSHR (eFSHR); these include one constitutively activation variant, one allelic variant, and five inactivating variants. These mutations were introduced into wild-type eFSHR (eFSHR-wt) sequence to generate mutants that were designated as eFSHR-D566G, -A306T, -A189V, -N191I, -R572C, -A574V, and -R633H. Mutants were transfected into PathHunter EA-parental CHO-K1 cells expressing β-arrestin. The biological function of mutants was analyzed by quantitating cAMP accumulation in cells incubated with increasing concentrations of FSH. Results: Cells expressing eFSHR-D566G exhibited an 8.6-fold increase in basal cAMP response, as compared to that in eFSHR-wt. The allelic variation mutant eFSHR-A306T was not found to affect the basal cAMP response or half maximal effective concentration (EC50) levels. On the other hand, eFSHR-D566G and eFSHR-A306T displayed a 1.5- and 1.4-fold increase in the maximal response, respectively. Signal transduction was found to be completely impaired in case of the inactivating mutants eFSHR-A189V, -R572C, and -A574V. When compared with eFSHR-wt, eFSHR-N191I displayed a 5.4-fold decrease in the EC50 levels (3,910 ng/mL) and a 2.3-fold decrease in the maximal response. In contrast, cells expressing eFSHR-R633H displayed in a similar manner to that of the cells expressing the eFSHR-wt on signal transduction and maximal response. Conclusion: The activating mutant eFSHR-D566G greatly enhanced the signal transduction in response to FSH, in the absence of agonist treatment. We suggest that the state of activation of the eFSHR can modulate its basal cAMP accumulation.

Abstract

Objective: Follicle-stimulating hormone (FSH) is the central hormone involved in mammalian reproduction, maturation at puberty, and gamete production that mediates its function by control of follicle growth and function. The present study investigated the mutations involved in the regulation of FSH receptor (FSHR) activation. Methods: We analyzed seven naturally-occurring mutations that were previously reported in human FSHR (hFSHR), in the context of equine FSHR (eFSHR); these include one constitutively activation variant, one allelic variant, and five inactivating variants. These mutations were introduced into wild-type eFSHR (eFSHR-wt) sequence to generate mutants that were designated as eFSHR-D566G, -A306T, -A189V, -N191I, -R572C, -A574V, and -R633H. Mutants were transfected into PathHunter EA-parental CHO-K1 cells expressing β-arrestin. The biological function of mutants was analyzed by quantitating cAMP accumulation in cells incubated with increasing concentrations of FSH. Results: Cells expressing eFSHR-D566G exhibited an 8.6-fold increase in basal cAMP response, as compared to that in eFSHR-wt. The allelic variation mutant eFSHR-A306T was not found to affect the basal cAMP response or half maximal effective concentration (EC50) levels. On the other hand, eFSHR-D566G and eFSHR-A306T displayed a 1.5- and 1.4-fold increase in the maximal response, respectively. Signal transduction was found to be completely impaired in case of the inactivating mutants eFSHR-A189V, -R572C, and -A574V. When compared with eFSHR-wt, eFSHR-N191I displayed a 5.4-fold decrease in the EC50 levels (3,910 ng/mL) and a 2.3-fold decrease in the maximal response. In contrast, cells expressing eFSHR-R633H displayed in a similar manner to that of the cells expressing the eFSHR-wt on signal transduction and maximal response. Conclusion: The activating mutant eFSHR-D566G greatly enhanced the signal transduction in response to FSH, in the absence of agonist treatment. We suggest that the state of activation of the eFSHR can modulate its basal cAMP accumulation.

참고문헌 (49)

  1. Simoni M, "Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: identification and characterization of two discrete FSH receptor isoforms", J Clin Endocrinol Metab, 84, pp.751~755 (1999)[DOI]
  2. Min KS, "Mutations that induce constitutive activations and mutations that impair signal transduction modulate the basal and", or agonist-stimulated internalization of the lutropin, J Biol Chem, pp.1998, 273[DOI]
  3. Krishnamurthy H, "Postendocytotic trafficking of the follicle-stimulating hormone(FSH)-FSH receptor complex", Mol Endocrinol, 17, pp.2162~2176 (2003)[DOI]
  4. Bhaskaran RS, "The post-endocytotic fate of the gonadotropin receptors is an important determinant of the desensitization of gonadotropin responses", J Mol Endocrinol, 34, pp.447~457 (2005)[DOI]
  5. Banerjee AA, "Role of the extracellular and intracellular loops of follicle-stimulating hormone receptor in its function", Front Endocrinol, 6, pp.110~ (2015)[DOI]
  6. Aittomaki K, "Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure", Cell, 82, pp.956~968 (1995)[DOI]
  7. Gromoll J, "An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man", J Clin Endocrinol Metab, 84, pp.1367~1370 (1996)[DOI]
  8. Gromoll J, "Functional and clinical consequences of mutations in the FSH receptor", Mol Cell Endocrinol, 125, pp.177~182 (1996)[DOI]
  9. Tao YX, "Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III", Mol Endocrinol, 14, pp.1272~1282 (2000)[DOI]
  10. Tao YX, "Chimeras of the rat and human FSH receptors (FSHRs) identify residues that permit or suppress transmembrane 6 mutation-induced constitutive activation of the FSHR via rearrangements of hydrophobic interactions between helices 6 and 7", Mol Endocrinol, 16, pp.1881~1892 (2002)[DOI]
  11. Zhang M, "Intrinsic differences in the response of the human lutropin receptor versus the human follitropin receptor to activating mutations", J Biol Chem, 282, pp.25527~25539 (2007)[DOI]
  12. Ghezelayagh Z, "The impact of genetic variation and gene expression level of the folliclestimulating hormone receptor on ovarian reserve", Cell J, 19, pp.620~626 (2018)[DOI]
  13. Simoni M, "The follicle-stimulating hormone receptor : biochemistry, molecular biology, physiology, and pathophysiology", Endocr Rev, 18, pp.739~773 (1997)[DOI]
  14. Kleinau G, "Thyrotropin and homologous glycoprotein hormone receptors : structural and functional aspects of extracellular signaling mechanisms", Endocr Rev, 30, pp.133~151 (2009)[DOI]
  15. Laue L, "Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty", Proc Natl Acad Sci USA, 92, pp.1906~1910 (1995)[DOI]
  16. Kraaij R, "A missense mutation in the second transmembrane segment of the luteinizing hormone receptor causes familial male-limited precocious puberty", J Clin Endcrinol Metab, 80, pp.3168~3172 (1995)[DOI]
  17. Whitney EA, "The follicle-stimulating hormone receptor gene is polymorphic in premature ovarian failure and normal controls", Fertil Steril, 64, pp.518~524 (1995)[DOI]
  18. Fuller PJ, "No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors", J Clin Endocrinol Metab, 83, pp.274~279 (1998)[DOI]
  19. Bas F, "No activating mutations of FSH receptor in four children with ovarian juvenile granulosa cell tumors and the association of these tumors with central precocious puberty", J Pediatr Adolesc Gynecol, 22, pp.173~179 (2009)[DOI]
  20. Aittomaki K, "Clinical features of primary ovarian failure caused by a point mutation in the follicle-stimulating hormone receptor gene", J Clin Endocrinol Metab, 81, pp.3722~3726 (1996)[DOI]
  21. Tapanainen JS, "Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility", Nat Genet, 15, pp.205~206 (1997)[DOI]
  22. Liu X, "Disruption of potential sites for N-linked glycosylation does not impair hormone binding to the lutropin", choriogonadotropin receptor if Asn-173 is left intact, 1993, pp.268, 1513~1516
  23. Davis D, "Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function", Mol Endocrinol, 9, pp.159~170 (1995)[DOI]
  24. Beau I, "A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor", J Clin Invest, 102, pp.1352~1359 (1998)[DOI]
  25. Desai SS, "Functional characterization of two naturally occurring mutations (Val514Ala and Ala575Val) in follicle-stimulating hormone receptor", J Clin Endocrinol Metab, 100, pp.E635~E645 (2015)[DOI]
  26. Touraine P, "New natural inactivating mutations of the follicle-stimulating hormone receptor : correlations between receptor function and phenotype", Mol Endocrinol, 13, pp.1844~1854 (1999)[DOI]
  27. Hugon-Rodin J, "First mutation in the FSHR cytoplasmic tail identified in a non-pregnant woman with spontaneous ovarian hyperstimulation syndrome", BMC Med Genet, 18, pp.44~ (2017)[DOI]
  28. Desai SS, "Follicle-stimulating hormone receptor polymorphism(G-29A)is associated with altered level of receptor expression in granulosa cells", J Clin Endocrinol Metab, 96, pp.2805~2812 (2011)[DOI]
  29. Katari S, "Novel inactivating mutation of the FSH receptor in two siblings of Indian origin with premature ovarian failure", J Clin Endocrinol Metab, 100, pp.2154~2157 (2015)[DOI]
  30. Bramble MS, "A novel folliclestimulating hormone receptor mutation causing primary ovarian failure : a fertility application of whole exome sequencing", Hum Reprod, 31, pp.905~914 (2016)[DOI]
  31. Liu H, "A novel homozygous mutation in the FSHR gene is causative for primary ovarian insufficiency", Fertil Steril, 108, pp.1050~1055 (2017)[DOI]
  32. Byambaragchaa M, "Constitutive activation and inactivation of mutations inducing cell surface loss of receptor and impairing of signal transduction of agoniststimulated eel follicle-stimulating hormone receptor", Int J Mol Sci, 21, pp.7075~ (2020)[DOI]
  33. Byambaragchaa M, "Site specificity of eel luteinizing hormone N-linked oligosaccharides in signal transduction", Gen Comp Endocrinol, 268, pp.50~56 (2018)[DOI]
  34. Morkrosiryski J, "Modulation of constitutive activity and signaling bias of the ghrelin receptor by conformational constraint in the second extracellular loop", J Biol Chem, 287, pp.33488~33502 (2012)[DOI]
  35. Kudo M, "Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop", J Biol Chem, 271, pp.22470~22478 (1996)[DOI]
  36. Bradbury FA, "Posttranslational processing in the Golgi plays a critical role in the trafficking of the luteinizing hormone", human chorionic gonadotropin receptor to the cell surface, 1997, pp.272, 5921~5926
  37. Nakamura K, "Signaling and phosphorylation-impaired mutants of the rat follitropin receptor reveal an activation-and phosphorylation-independent but arrestin-dependent pathway for internalization", J Biol Chem, 273, pp.24346~24354 (1998)[DOI]
  38. Schulz A, "Role of the third intracellular loop for the activation of gonadotropin receptors", Mol Endocrinol, 13, pp.181~190 (1999)[DOI]
  39. Haywood M, "An activated human follicle-stimulating hormone (FSH) receptor stimulates FSH-like activity in gonadotropin-deficient transgenic mice", Mol Endocrinol, 16, pp.2582~2591 (2002)[DOI]
  40. NordhoffV, "Targeted expression of human FSH receptor Asp567Gly mutant mRNA in testis of transgenic mice : role of the human FSH receptor promoter", Asian J Androl, 5, pp.267~275 (2003)
  41. Allan CM, "Transgenic mutant D567G but not wild-type human FSH receptor overexpression provides FSH-independent and promiscuous glycoprotein hormone Sertoli cell signaling", Am J Physiol Endocrinol Metab, 296, pp.E1022~E1028 (2009)[DOI]
  42. Loutradis D, "FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF", ICSI-ET programs, 2006, pp.23, 177~184
  43. De Koning CH, "The distribution of FSH receptor isoforms is related to basal FSH levels in subfertile women with normal menstrual cycles", Hum Reprod, 21, pp.443~446 (2006)[DOI]
  44. Du J, "Two FSHR variants, haplotypes and meta-analysis in Chinese women with premature ovarian failure and polycystic ovary syndrome", Mol Genet Metab, 100, pp.292~295 (2010)[DOI]
  45. Yarney TA, "Molecular cloning and expression of the ovine testicular follicle stimulating hormone receptor", Mol Cell Endocrinol, 93, pp.219~226 (1993)[DOI]
  46. Houde A, "Structure of the bovine follicle-stimulating hormone receptor complementary DNA and expression in bovine tissues", Mol Reprod Dev, 39, pp.127~135 (1994)[DOI]
  47. Robert P, "Cloning and sequencing of the equine testicular follitropin receptor", Biochem Biophys Res Commun, 201, pp.201~207 (1994)[DOI]
  48. Rannikko A, "Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation", Mol Hum Reprod, 8, pp.311~317 (2002)[DOI]
  49. Tao YX, "Inactivating mutations of G protein-coupled receptors and diseases : structure-function insights and therapeutic implications", Pharmacol Ther, 111, pp.949~973 (2006)[DOI]

관련 논문AI추천

Constitutive Activating Eel Luteinizing Hormone Receptors Induce Constitutively Signal Transduction and Inactivating Mutants Impair Biological Activity민관식, Dong-Wan Kim, Munkhzaya Byambaragchaa, Seung-Hee Choi한국발생생물학회 · 발생과 생식2021 · 제25권 제3호Signal Transduction of Constitutive Activating and Inactivating Eel Lutropin/ Choriogonadotropin Receptor (Eel LH/ CGR) Mutants by Recombinant Equine Chorionic Gonadotropin (Rec-eCG)민관식, 박재혁, 정하린, Munkhzaya Byambaragchaa, Sei Hyen Park한국발생생물학회 · 발생과 생식2024 · 제28권 제4호The C-terminal Phosphorylation Sites of eel Follicle-Stimulating Hormone Receptor are Important Role in the Signal Transduction강명화, 민관식, Jeong-Min Kim, Munkhzaya Byambaragchaa한국발생생물학회 · 발생과 생식2018 · 제22권 제2호Signal Transduction of C-Terminal Phosphorylation Regions for Equine Luteinizing Hormone/Chorionic Gonadotropin Receptor (eLH/CGR)민관식한국발생생물학회 · 발생과 생식2022 · 제26권 제1호Cell-Surface Loss of Constitutive Activating and Inactivating Mutants of Eel Luteinizing Hormone Receptors민관식, Dong-Wan Kim1, Munkhzaya Byambaragchaa, Seung-Hee Choi한국발생생물학회 · 발생과 생식2021 · 제25권 제4호Internalization of Rat FSH and LH/CG Receptors by rec-eCG in CHO-K1 Cells강명화, 김정수, 민관식, 박종주, 성훈기, Byambaragchaa Munkhzaya한국발생생물학회 · 발생과 생식2017 · 제21권 제2호

이 간행물의 다른 논문 (14건)